Connecting for innovation and impact for all in global health
On February 25, Neha Agarwal, senior director of strategy at PATH and Alliance board vice chair, led a session for Stanford Mussallem Center for Biodesign’s Innovation and Health Equity Series. She discussed how outcomes-based financing (OBF) can be leveraged to tackle antimicrobial resistance (AMR). Her talk, which provided a first look at data from a year-long study in Tanzania and Senegal, emphasized how innovative financing mechanisms could reshape global health strategies.
As the potential impact of generative AI (GenAI) on health in low- and middle-income countries (LMICs) continues to be explored, two key questions emerge: Where is GenAI currently being used most effectively, and how can its full potential be unlocked for greater impact, both for behavior change and broader healthcare applications? A newly released white paper sheds light on these questions, offering insights from a comprehensive review led by the Stanford Center for Digital Health (CDH) with support from Advancing Health Online (AHO) and the Bay Area Global Health Alliance as lead dissemination partner.
This event hosted by JSI will explore how human-centered technology can transform community health information systems, making them more effective, sustainable, and scalable. In a sector where data is essential, the discussion will focus on how technology can generate, simplify access to, and translate data into actionable insights for government stakeholders and community health workers.
Americares, FHI 360, Global Health Council, JSI, PATH, ReSurge International, UNICEF USA Read More
Join Stanford Mussallem Center for Biodesign on February 25 for the next session in their Innovation and Health Equity Discussion Series where Neha Agarwal, senior director of strategy at PATH and Alliance board vice chair, will discuss an innovative outcomes-based financing (OBF) mechanism being developed in partnership with the governments of Tanzania and Senegal, the Bay Area Global Health Alliance, and Pfizer to reinforce antimicrobial stewardship efforts in LMICs.
DNDi, PATH Read More
PATH Read More
PATH Read More
In light of recent executive actions by President Donald Trump, our community faces new challenges and uncertainties that could significantly impact both global health initiatives and domestic health policies. These actions include the withdrawal from the World Health Organization (WHO), a pause in foreign assistance, a halt to the U.S. Department of Health and Human Services (HHS) communications, and restrictions on National Institutes of Health (NIH) operations, among others. The full ramifications of these actions are still unfolding, with numerous legal interpretations and challenges anticipated. In our dedication to supporting our members, we have begun to gather initial insights and are actively working to understand this evolving landscape.
On Wednesday, January 15, the Bay Area Global Health Alliance hosted a panel discussion, “Realizing Returns: Investment Opportunities in Emerging Markets,” at the 2025 J.P. Morgan Healthcare Conference (JPM) in San Francisco, followed by a reception to continue the conversation, “Private Sector Finance for Global Health: Investing for Impact and Equity,” held at Accenture San Francisco Innovation Hub. Together, these discussions explored investment opportunities in global health and partnerships using innovative financing models to drive both business and social returns in emerging markets.
The Alliance congratulates our Deputy Director Abbey Kocan and many other women leaders among our members for being selected as emerging leaders as part of WomenLift Health’s sixth North America Cohort of the Leadership Journey, a fully-funded leadership initiative designed to support women through the challenges and opportunities of advancing to senior leadership positions in global health.
PATH Read More
PATH Read More
PATH Read More
PATH Read More
With global commitments to universal health coverage by 2030 (UHC2030) and primary health care (PHC) as the approach to achieving sustainable health for all, PATH is hosting an engaging webinar that will consider how HIV services are being included in essential care packages, highlight integration approaches, and convene an expert panel of community representatives, advocates, and funders who will share considerations for designing, implementing, and financing integrated and inclusive HIV-PHC models to ensure long-term sustainability as part of country-specific UHC2030 goals. Panelists include Alliance member Chris Collins, President & CEO of Friends of the Global Fight and moderator Dr. Kimberly Green, Global Director, Primary Healthcare of PATH.
During the Clinton Global Initiative (CGI) 2024 Annual Meeting, PATH, in partnership with the Bay Area Global Health Alliance and Pfizer, announced a Commitment to Action: Outcomes-Based Financing as a Tool to Curb AMR in LMICs. This commitment aims to combat antimicrobial resistance (AMR) and incentivize antimicrobial stewardship (AMS) through an innovative outcomes-based financing mechanism.
PATH Read More
PATH Read More
PATH Read More